Dong Yanfang, Chen Yunfeng, Zhou Limei, Shao Yu, Fu Xianzhi, Zheng Yi
a Research Institute of Photocatalysis, State Key Laboratory of Photocatalysis on Energy and Environment , Fuzhou University , Fuzhou , P.R. China.
Int J Radiat Biol. 2017 Nov;93(11):1274-1282. doi: 10.1080/09553002.2017.1366673. Epub 2017 Sep 1.
To investigate the molecular aspects of the synergy between ionizing radiation and platinum (Pt) chemotherapeutic agents in cancer treatment with chemoradiation therapy (CRT) by measuring damages induced by low-energy electrons (LEE) to DNA bound to cisplatin. LEE are produced abundantly by any type of ionizing radiation and cisplatin represents a typical Pt-chemotherapeutic agents.
Our strategy involves two parallel administrations of cisplatin and irradiation with a 4.6 and 9.6 eV electron fluence of 1.1 × 10: (1) LEE bombardment of supercoiled DNA and its subsequent reaction with cisplatin; (2) the reaction of DNA with cisplatin followed by LEE irradiation. The damage yields for the loss of supercoiled (LS), single-strand breaks (SSB) and double-strand breaks (DSB) were obtained from gel electrophoresis analysis. Base modifications were revealed by treating the samples with Escherichia coli base excision repair endonuclease (Nth and Fpg).
The yields were deduced from the respective time-response for the reaction of DNA with cisplatin. The results show that binding cisplatin to DNA followed by LEE irradiation, consistently yields more DNA damages than the reverse order. In comparison to non-treated DNA, administration (2) results in an increase of LS and SSB of 1.4-3.3 folds and of DSB by more than an order of magnitude. Furthermore, after enzyme treatment, the yields of DSB rise by factors of 5.3-15.4, indicating a large increase of clustered damages, which should at least partially translate into an increase of lethal damages in cancer cells during the CRT.
Our results demonstrate that a strong synergy between radiation and cisplatin can only be achieved at the molecular level, if the drug is present at the time of irradiation. Furthermore, this work confirms the LEE mechanism previously proposed to explain the synergy between radiation and Pt drugs in CRT. It involves chemical sensitization of DNA prior to irradiation, to facilitate strand breaks and clustered damages induced by the highly reactive LEE.
通过测量低能电子(LEE)对与顺铂结合的DNA造成的损伤,研究电离辐射与铂(Pt)化疗药物在放化疗(CRT)治疗癌症过程中的协同作用的分子机制。任何类型的电离辐射都会大量产生LEE,顺铂是一种典型的铂类化疗药物。
我们的策略包括顺铂的两种平行给药方式以及分别用4.6和9.6电子伏特、通量为1.1×10的电子进行辐照:(1)用LEE轰击超螺旋DNA及其随后与顺铂的反应;(2)DNA与顺铂反应后再进行LEE辐照。通过凝胶电泳分析获得超螺旋丧失(LS)、单链断裂(SSB)和双链断裂(DSB)的损伤产额。用大肠杆菌碱基切除修复内切酶(Nth和Fpg)处理样品以揭示碱基修饰情况。
产额是根据DNA与顺铂反应各自的时间响应推导得出的。结果表明,先让顺铂与DNA结合然后进行LEE辐照,始终比相反顺序产生更多的DNA损伤。与未处理的DNA相比,给药方式(2)导致LS和SSB增加1.4至3.3倍,DSB增加超过一个数量级。此外,酶处理后,DSB产额增加5.3至15.4倍,表明聚集损伤大幅增加,这在CRT期间应至少部分转化为癌细胞致死损伤的增加。
我们的结果表明,只有在辐照时存在药物,才能在分子水平上实现辐射与顺铂之间的强协同作用。此外,这项工作证实了先前提出的LEE机制,以解释CRT中辐射与铂类药物之间的协同作用。它涉及辐照前DNA的化学敏化,以促进由高反应性LEE诱导的链断裂和聚集损伤。